Bin

Bin Ma has a diverse work experience in the field of scientific research and development. Bin Ma started as a Scientist at Celerion in 2023. Prior to that, Bin Ma worked at the University of Nebraska-Lincoln as a Research and Teaching Assistant from 2017 to 2022, where they focused on bioorthogonal reaction development, Tetrazine-Alkene protein labeling reaction, and Tetrazine synthesis. Before that, Bin Ma served as a Senior Scientist and Manager at Yangzhou Tianhe Pharmaceutical Co., Ltd. from 2013 to 2017, where they were responsible for reaction condition optimization, building up the lab, and organic synthesis and HPLC analysis. Bin Ma also worked as a Scientist at WuXi AppTec from 2011 to 2013, specializing in multi-step synthesis for drug candidate screening, structure analysis using H-NMR, C-NMR, LCMS, HPLC, and organic compound purification.

Bin Ma obtained a Bachelor's degree in Medicinal and Pharmaceutical Chemistry from Huazhong University of Science and Technology in 2008. Bin then pursued a Master's degree in the same field at the University of Chinese Academy of Sciences from 2008 to 2011. Most recently, from 2017 to 2022, Bin Ma attended the University of Nebraska-Lincoln, where they completed their Doctor of Philosophy (PhD) in Medicinal and Pharmaceutical Chemistry.